This Thursday, Jan 25th is our next Clean Sweep Live Auction: Click to view the full catalogue and pre-bid now

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Endoscopy Homepage

David Woods PENTAX Medical appoints veteran executive as the Americas region president and CEO

DePuy Synthes unveils PUREVUE Visualization System An imaging platform for minimally-invasive endoscopic surgery

Olympus expands its EndoTherapy product line One new device and two business deals

Dr. Adam J. Goodman NYU Langone Hospital – Brooklyn hires a new director of endoscopy and quality to its department of medicine.

FDA greenlights first duodenoscope with disposable distal cap Reduces risk for transfer of infections between patients

Optim LLC launches video endoscopy System for ENT disorders in the U.S. System provides visual diagnosis for Ear-Nose-and-Throat disorders

Penn Medicine neurosurgeon performs first endoscopic spinal surgery in the state May treat spinal column and cord tumors in the future

New PENTAX Medical ultrasound endoscope available in U.S. Can be used to assess and treat conditions of the pancreaticobiliary system

Intuitive Surgical enters licensing agreement with JustRight Surgical Merging laparoscopic tools with robotic surgery

Harvard team develops small, soft robotic arm for endoscopic surgery Potential disposable device for OR

Creo Medical's Speedboat RS2 gains FDA clearance 'ahead of schedule'

by Thomas Dworetzky , Contributing Reporter
Creo Medical Group's Speedboat RS2 device and its CROMA platform received 510(k) clearance, the surgical endoscopic device maker has announced.

Speedboat RS2, powered by the microwave-based CROMA platform, permits “minimally invasive” endoscopic removal of early stage cancerous and precancerous lesions in the bowel.

Story Continues Below Advertisement

Streamline Your Radiology Workflow with RamSoft's PowerServer RIS/PACS

The PowerServer RIS/PACS is a single database application, essential to reducing redundant work, limiting manual data entry, and increasing consistency throughout healthcare practices. Click to learn how it will help you improve patient care and more.

This FDA review took just 49 days, and will let the Wales-based company turn its attention to U.S. commercial planning early.

"We continue to execute against our plan and, in this case, come in well ahead of our targets,” said CREO CEO Craig Gulliford, adding that, “this bodes well and provides us with confidence that we have the foundation in place to execute on the suite of devices currently in development."

The approval came almost two quarters ahead of schedule.

"The next step is to roll out the training course that is underway in Europe at the moment and start rolling that into physicians in the U.S.," he told Reuters.

Speedboat RS2 is the first of a number of planned devices that will use the CROMA generator.

The use of Speedboat RS2 “reduces the risks associated with incisions, which are necessary for laparoscopic procedures and can reduce the length of hospital stay,” the company stated, noting that this is due to its ability to coagulate bleeding vessels with its microwave energy, and to cut or resect with that energy, with minimal risk of puncturing surrounding tissue.

The device has a number of features, including:

  • Its ability to maintain submucosal lift with an integrated injection needle, with no instrument changes required

  • Bipolar radiofrequency cutting for precise lateral and forward dissection

  • Microwave coagulation, providing controlled hemostasis

  • A protective hull, reducing risk of muscle damage

  • An optimized shaft design, enabling controlled rotation

There are now more than 16 million colonoscopies performed annually, and 1.1 million of these find a lesion that needs treatment, of which half are surgically removed.

"Surgical endoscopy is an emerging field and we believe that with the CROMA system, Speedboat and our suite of products, we are well positioned to become a leader in this billion-dollar-plus market," advised Gulliford.

In March, the Speedboat RS2 received its CE Mark approval for microwave energy to add to the device's previously awarded CE Mark for radiofrequency.

Clinical studies had shown it to be safe and efficacious in the application of microwave energy to coagulate bleeds in the colon in 30 patients, according to a report published in Digestive Disease Week at that time.

In 2016, Creo made its stock market debut and raised over $26.5 million from investors. At that time, Gulliford told the Telegraph, “our product enables procedures that are currently only done in the operating theatre to be done in the endoscopy room, so we go from requirement of a general anesthetic to a local one or sedation.”

“It’s using God-given access to a body rather than an incision,” he added, noting, “The other thing that makes this different is that the microwave energy that stops the blood flow can be delivered in a very precise, minimal way."

Endoscopy Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.